Forschung & Innovation
Publikationen
Irinotecan in combination with 5-fluorouracil and folinic acid or with cisplatin in patients with advanced gastric or esophageal-gastric junction adenocarcinoma: results of a randomized phase II study.
PMU Autor*in
Johannes Bükki
Alle Autor*innen
C. Pozzo, C. Barone, J. Szanto, E. Padi, C. Peschel, Johannes Bükki, V. Gorbunova, V. Valvere, J. Zaluski, M. Biakhov, E. Zuber, C. Jacques, R. Bugat
Fachzeitschrift
ANNALS OF ONCOLOGY
Kurzfassung
Keywords
TRIAL, DOXORUBICIN, METASTATIC COLORECTAL-CANCER, HIGH-DOSE METHOTREXATE, PLUS SUPPORTIVE CARE, EUROPEAN-ORGANIZATION, ADJUVANT CHEMOTHERAPY, FLUOROURACIL FAILURE, COOPERATIVE GROUP, LEUCOVORIN